Large-scale testing (Phase 3)Study completedNCT04029116
What this trial is testing
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
Who this might be right for
Recurrent Vulvovaginal Candidiasis
Scynexis, Inc. 440